Organ Transplant Risks: Surgical Complications, Long-Term Effects, and Success Factors

Organ transplantation is life-saving for end-stage organ failure but carries significant risks that must be weighed against benefits.

1. Perioperative Surgical Risks

  • Bleeding (coagulopathy, vascular anastomoses).
  • Infection (wound, urinary, pneumonia, sepsis).
  • Vascular thrombosis (hepatic artery, renal artery/vein, portal vein).
  • Biliary complications (leak, stricture – liver).
  • Primary graft non-function (PGNF) or delayed graft function (DGF – kidney).
  • Reperfusion injury (oxidative stress, inflammation).

2. Immunosuppression-Related Long-Term Risks

  • Infections: Opportunistic (CMV, BK virus, EBV-PTLD, PJP, fungi) – highest first 6–12 months.
  • Malignancy: 2–4× increased risk; skin cancer (SCC, BCC), PTLD, Kaposi sarcoma, cervical, vulvar, anal (HPV-related).
  • Cardiovascular: Accelerated atherosclerosis (steroids, CNIs, mTORi), hypertension, dyslipidemia, diabetes (NODAT).
  • Renal Dysfunction: CNI nephrotoxicity (tacrolimus, cyclosporine) → chronic allograft nephropathy / interstitial fibrosis.
  • Metabolic/Bone: New-onset diabetes, osteoporosis, fractures, gout.
  • Neurotoxicity: Tremor, headache, seizures, PRES (CNIs).

3. Donor-Recipient Factors

  • Compatibility: ABO blood group, HLA matching (critical for kidney/pancreas; less for liver/heart), crossmatch negative.
  • Donor Quality: Age, cause of death, DCD vs. DBD, steatosis (liver), KDPI (kidney).
  • Recipient Health: Frailty, malnutrition, active infection, malignancy, non-adherence history, psychosocial stability.

4. Post-Transplant Adherence

  • Lifelong immunosuppression (typically triple: CNI + antimetabolite + steroid, or CNI + mTORi).
  • Strict medication compliance, lab monitoring, clinic visits, infection prophylaxis, cancer screening.
  • Lifestyle: no smoking, limited alcohol, sun protection, exercise, healthy weight.

Outcomes

  • 1-year graft survival: Kidney 95%, Liver 90%, Heart 88%, Lung 85%.
  • Half-life of deceased donor kidney: ~12–15 years; living donor ~20+ years.
  • Quality of life generally superior to dialysis/heart failure.

Decision involves multidisciplinary transplant team; informed consent requires thorough discussion of risks, alternatives, and expected outcomes.

Kidney Disease - Related Articles